The role of mucosal serotonin in visceral nociception and gut motility

粘膜血清素在内脏伤害感受和肠道蠕动中的作用

基本信息

  • 批准号:
    10710171
  • 负责人:
  • 金额:
    $ 7.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-07 至 2025-09-06
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Irritable bowel syndrome (IBS) is a highly prevalent disorder characterized by visceral pain and dysmotility. IBS causes substantial morbidity in children and adults and current therapy is inadequate. Serotonin (5-HT) signaling plays roles in pain and motility, but the efficacy of modifying 5-HT signaling to treat IBS is limited and fraught with adverse effects. A greater understanding of how enteric 5-HT contributes to IBS pathophysiology may therefore provide for novel and effective treatments for the condition. Enterochromaffin (EC) cells in the gastrointestinal (GI) epithelium produce most of the 5-HT in the gut, which is thought to stimulate extrinsic primary afferent neuron (ExPAN) and intrinsic primary afferent neuron (IPAN) terminals to promote sensory and motor signaling, respectively. The serotonin reuptake transporter (SERT), present throughout epithelial cells, rapidly inactivates 5-HT. Selective serotonin reuptake inhibitors (SSRIs) inhibit SERT and thus increase 5-HT availability for IPAN and ExPAN stimulation. Despite their use for pediatric IBS, SSRIs are often ineffective and plagued by adverse GI effects, which may be due to their effects at sites other than the GI epithelium. My prior and preliminary data strongly suggest that epithelial-restricted 5-HT modulation may limit unwanted effects and thus improve therapy. My data also show a novel visceral pain mechanism involving SERT regulation of mucosal 5- HT. In the current proposal, I will investigate the effects of epithelial 5-HT on GI motility and visceral nociception using optogenetic tools that induce or inhibit EC cell secretion, mouse lines that either lack mucosal 5-HT or SERT, and pharmacological interventions that alter mucosal 5-HT signaling. The proposed research strategy will allow me to test the hypotheses that 1) 5-HT released from EC cells and 2) SERT-mediated regulation of mucosal 5-HT availability modulate visceral nociception and GI motility.
项目总结/摘要 肠易激综合征(IBS)是一种以内脏疼痛和动力障碍为特征的高度流行的疾病。 IBS导致儿童和成人的大量发病率,目前的治疗是不够的。5-羟色胺 信号传导在疼痛和运动中起作用,但修饰5-HT信号传导以治疗IBS的功效有限, 充满了负面影响更深入地了解肠道5-HT如何促进IBS病理生理学 因此可以为该病症提供新的和有效的治疗。肠嗜铬(EC)细胞在 胃肠道(GI)上皮细胞在肠道中产生大部分5-HT,这被认为是刺激外源性原发性 传入神经元(ExPAN)和内源性初级传入神经元(IPAN)末梢,以促进感觉和运动 信号,分别。5-羟色胺再摄取转运蛋白(SERT),存在于整个上皮细胞,迅速 灭活5-HT。选择性5-羟色胺再摄取抑制剂(SSRIs)抑制SERT,从而增加5-HT的可用性 用于IPAN和ExPAN刺激。尽管SSRIs用于儿科IBS,但它们通常无效,并受到以下因素的困扰: 胃肠道不良反应,这可能是由于其对胃肠道上皮以外部位的影响。我的副院长和 初步数据强烈提示,上皮限制性5-HT调节可能限制不必要的作用, 改善治疗。我的数据还显示了一种新的内脏疼痛机制,涉及SERT调节粘膜5- HT。在本研究中,我将研究上皮细胞5-HT对胃肠道运动和内脏伤害性感受的影响 使用诱导或抑制EC细胞分泌的光遗传学工具, SERT和改变粘膜5-HT信号传导的药理学干预。拟议的研究战略 将允许我测试假设,1)5-HT从EC细胞释放和2)SERT介导的调节, 粘膜5-HT可用性调节内脏伤害感受和GI运动。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sarah Najjar其他文献

Sarah Najjar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sarah Najjar', 18)}}的其他基金

The role of mucosal serotonin in visceral nociception and gut motility
粘膜血清素在内脏伤害感受和肠道蠕动中的作用
  • 批准号:
    10535862
  • 财政年份:
    2022
  • 资助金额:
    $ 7.18万
  • 项目类别:

相似海外基金

Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
  • 批准号:
    24K11201
  • 财政年份:
    2024
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
  • 批准号:
    24K11281
  • 财政年份:
    2024
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
  • 批准号:
    EP/Z001145/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
  • 批准号:
    2338890
  • 财政年份:
    2024
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334777
  • 财政年份:
    2024
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334775
  • 财政年份:
    2024
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334776
  • 财政年份:
    2024
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Continuing Grant
Cryo laser-ablation system (157+193nm) with 'triple-quad' plasma mass spectrometer, Cryo-LA-ICPMS/MS
带有“三重四极杆”等离子体质谱仪、Cryo-LA-ICPMS/MS 的冷冻激光烧蚀系统 (157 193nm)
  • 批准号:
    515081333
  • 财政年份:
    2023
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Major Research Instrumentation
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
  • 批准号:
    2320040
  • 财政年份:
    2023
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了